INNOVIVA, INC. Increase (Decrease) in Inventories
INNOVIVA, INC. (INVA) reported Increase (Decrease) in Inventories of $2.34 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05
- INNOVIVA, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $1.03M, a 87.14% decline year-over-year.
- INNOVIVA, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $1.31M, a 85.69% decline year-over-year.
- INNOVIVA, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $2.62M, a 116.89% increase year-over-year.
- INNOVIVA, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$6.85M.
- INNOVIVA, INC. increase (decrease) in inventories for fiscal 2025 was $12.92M, a 89.76% increase from fiscal 2024.
- INNOVIVA, INC. increase (decrease) in inventories for fiscal 2024 was $6.81M, a 43.29% decline from fiscal 2023.
- INNOVIVA, INC. increase (decrease) in inventories for fiscal 2023 was $12.00M.
- INNOVIVA, INC. increase (decrease) in inventories for fiscal 2022 was -$280.00K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.34M 10-Q · filed 2026-08-05 | $4.96M derived: sum of 3 quarters · filed 2026-08-05 | -$1.89M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.31M 10-Q · filed 2026-05-06 | $3.93M derived: sum of 2 quarters · filed 2026-05-06 | -$2.92M derived: sum of 3 quarters · filed 2026-05-06 | $5.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$4.23M derived: sum of 2 quarters · filed 2026-02-25 | $3.77M derived: sum of 3 quarters · filed 2026-08-05 | $12.92M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$6.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.15M derived: sum of 2 quarters · filed 2026-08-05 | $10.30M 10-Q · filed 2025-11-05 | $11.51M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $7.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $17.15M 10-Q · filed 2026-08-05 | $18.35M derived: sum of 3 quarters · filed 2026-08-05 | $17.72M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $9.15M 10-Q · filed 2026-05-06 | $10.36M derived: sum of 2 quarters · filed 2026-05-06 | $9.73M derived: sum of 3 quarters · filed 2026-05-06 | $12.42M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $575.00K derived: sum of 2 quarters · filed 2026-02-25 | $3.27M derived: sum of 3 quarters · filed 2026-02-25 | $6.81M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$633.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.06M derived: sum of 2 quarters · filed 2025-11-05 | $5.60M 10-Q · filed 2025-11-05 | $13.81M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $6.23M 10-Q · filed 2025-08-06 | $14.44M derived: sum of 3 quarters · filed 2026-02-25 | $13.54M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $3.54M 10-Q · filed 2025-05-07 | $11.75M derived: sum of 2 quarters · filed 2026-02-25 | $10.85M derived: sum of 3 quarters · filed 2026-02-25 | $14.95M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $8.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $7.30M derived: sum of 2 quarters · filed 2026-02-25 | $11.41M derived: sum of 3 quarters · filed 2026-02-25 | $12.00M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$902.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $3.20M derived: sum of 2 quarters · filed 2024-11-06 | $3.80M 10-Q · filed 2024-11-06 | $3.87M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $4.70M 10-Q · filed 2024-07-31 | $4.77M derived: sum of 3 quarters · filed 2025-02-26 | $4.42M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $598.00K 10-Q · filed 2024-05-08 | $668.00K derived: sum of 2 quarters · filed 2025-02-26 | $318.00K derived: sum of 3 quarters · filed 2025-02-26 | $318.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$280.00K derived: sum of 2 quarters · filed 2025-02-26 | -$280.00K derived: sum of 3 quarters · filed 2025-02-26 | -$280.00K 10-K · filed 2025-02-26 |
| 2022-09-30 | -$350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$350.00K derived: sum of 2 quarters · filed 2023-11-01 | -$350.00K 10-Q · filed 2023-11-01 | -$350.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $0.00 10-Q · filed 2023-08-02 | $0.00 derived: sum of 3 quarters · filed 2024-03-05 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-03-05 | ||
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05 | $0.00 10-K/A · filed 2024-03-05 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 | |||
| 2016-12-31 | $0.00 10-K · filed 2017-02-28 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $0.00 10-K · filed 2017-02-28 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | $0.00 derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $0.00 derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $1.48M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $1.48M derived: sum of 3 quarters · filed 2017-02-28 | $1.91M 10-K · filed 2017-02-28 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $1.48M derived: sum of 2 quarters · filed 2015-11-05 | $1.91M 10-Q · filed 2015-11-05 | $2.10M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.91M 10-Q · filed 2015-08-06 | $2.10M derived: sum of 3 quarters · filed 2016-02-24 | $2.48M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | $430.00K 10-Q · filed 2015-05-08 | $618.00K derived: sum of 2 quarters · filed 2016-02-24 | $997.00K derived: sum of 3 quarters · filed 2016-02-24 | $1.05M derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $567.00K derived: sum of 2 quarters · filed 2016-02-24 | $619.00K derived: sum of 3 quarters · filed 2016-02-24 | $3.10M 10-K · filed 2016-02-24 |
| 2013-09-30 | $379.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $431.00K derived: sum of 2 quarters · filed 2014-11-04 | $2.91M 10-Q · filed 2014-11-04 | $3.17M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.53M 10-Q · filed 2014-08-07 | $2.79M derived: sum of 3 quarters · filed 2015-02-27 | $3.06M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $2.48M 10-Q · filed 2014-05-07 | $2.74M derived: sum of 2 quarters · filed 2015-02-27 | $3.00M derived: sum of 3 quarters · filed 2015-02-27 | |
| 2012-12-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $523.00K derived: sum of 2 quarters · filed 2015-02-27 | $4.82M 10-K · filed 2015-02-27 | |
| 2012-09-30 | $268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $4.57M 10-Q · filed 2013-11-01 | ||
| 2012-06-30 | $4.30M 10-Q · filed 2013-08-01 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |